An update on Zika vaccine developments

Epidemic arboviral diseases: priorities for research and public health

(2017) Annelies Wilder-Smith et al.   LANCET INFECTIOUS DISEASES

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

(2017) Norbert Pardi et al.   NATURE

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models

(2017) Chao Shan et al.   NATURE MEDICINE

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis

(2017) Xuping Xie et al.   mBio

Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

(2017) Megan R. Reynolds et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Zika Virus

(2016) Didier Musso et al.   CLINICAL MICROBIOLOGY REVIEWS

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease

(2016) Lesley J. Scott   DRUGS

Points for Consideration for dengue vaccine introduction – recommendations by the Dengue Vaccine Initiative

(2016) Jacqueline Kyungah Lim et al.   Expert Review of Vaccines

First Inactivated Zika Vaccine Trial

(2016) Jennifer Abbasi   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

(2016) Van-Mai Cao-Lormeau et al.   LANCET

Vaccine protection against Zika virus from Brazil

(2016) Rafael A. Larocca et al.   NATURE

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

(2016) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

DNA vaccines against Zika virus speed into clinical trials

(2016) Chris Morrison   NATURE REVIEWS DRUG DISCOVERY

Zika Virus Infection in Pregnant Women in Rio de Janeiro

(2016) Patrícia Brasil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia

(2016) Beatriz Parra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid development of a DNA vaccine for Zika virus

(2016) K. A. Dowd et al.   SCIENCE

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

(2016) P. Abbink et al.   SCIENCE

Zika Virus–Associated Neurological Disease in the Adult: Guillain–Barré Syndrome, Encephalitis, and Myelitis

(2016) Laura Muñoz et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency

(2016) K.S. Vannice et al.   VACCINE

Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells

(2015) Amporn Suphatrakul et al.   VACCINE

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties

(2014) Yan Liu et al.   BMC MICROBIOLOGY

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

(2013) Anna P. Durbin et al.   JOURNAL OF INFECTIOUS DISEASES

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

(2013) Samantha Brandler et al.   VACCINE

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

(2011) Julie E. Ledgerwood et al.   JOURNAL OF INFECTIOUS DISEASES

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

(2011) Beth-Ann G. Coller et al.   VACCINE

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

(2010) Samantha Brandler et al.   VACCINE

Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys

(2009) M. M. Lieberman et al.   Clinical and Vaccine Immunology

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE